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Abstract
Background: The main aim of this study was to investigate pre- and post-diagnostic physical activity (PA) levels, as
well as changes in pre- and post-diagnostic PA levels, and their association with all-cause and breast cancer-specific
mortality in women with breast cancer. Our study will add to the knowledge on whether a modifiable behavior
such as PA can improve survival.
Methods: We included 1,327 women with breast cancer from the population-based Norwegian Women and Cancer
study, which enrolled women from 1991 to 2003. Breast cancer cases were identified through linkage to the Cancer
Registry of Norway; date and cause of death were obtained from the National Register for Causes of Death through
31 December 2012. Self-reported pre- and post-diagnostic PA levels were assessed, and Cox proportional hazard
regression and spline regression were used to evaluate the associations.
Results: Pre-diagnostic PA levels were not associated with all-cause or breast cancer-specific mortality. Post-diagnostic
PA levels were associated with a significant trend (P < 0.001) of decreased all-cause and breast cancer-specific mortality,
which was stronger among older women (aged 50–74 years) and did not differ across categories of body mass index.
All-cause mortality (hazard ratio [HR] = 1.76, 95 % confidence interval [CI] 1.21–2.56) and breast cancer-specific mortality
(HR = 2.05, 95 % CI 1.35–3.10) increased among women who reduced their post-diagnostic PA level. These values were
similar among women whose maintained an inactive PA level pre- and post-diagnosis.
Conclusion: Overall, we observed a dose–response trend, with an inverse association between increased post-
diagnostic PA level and all-cause and breast cancer-specific mortality, as well as a higher mortality risk among women
who reduced their post-diagnostic PA levels. Our results are very promising for women with breast cancer, and indicate
that health care professionals should consider adding PA as a part of primary cancer treatment.
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Background
Breast cancer is the most common cancer among
women worldwide, accounting for 25 % of all new can-
cers [1]. Despite advances in early detection and treat-
ment, which have improved survival, breast cancer is the
second most frequent cause of cancer death among
women in most countries [1]. In the period 2008–2012
in Norway, the 5-year relative survival for patients diag-
nosed with breast cancer was 89 % [2].
Important research has revealed evidence that physical
activity (PA) can help relieve treatment-related symp-
toms and improve quality of life and physical function-
ing [3, 4] in breast cancer survivors, whose numbers are
increasing. Moreover, PA may decrease breast cancer
recurrence and extend overall breast cancer survival and
disease-free breast cancer survival [5–8]. However, in
their recently released report, the Continuous Update
Project of the World Cancer Research Fund concluded
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that there is limited evidence for an association between
pre-diagnostic and post-diagnostic PA levels and all-cause
and breast cancer-specific mortality among women with
breast cancer [9]. A recent meta-analysis included 49,095
breast cancer survivors and reported a 23 % decreased
relative risk of all-cause and breast cancer-specific mortal-
ity with increased PA levels [6]. Data from the Breast
Cancer Pooling Project indicated that engagement in at
least 10 metabolic equivalent (MET)-h/week (i.e., walking
2 miles in 30 min) of PA was associated with a 27 %
reduction in all-cause mortality and a 25 % reduction in
breast cancer-specific mortality among breast cancer sur-
vivors [10]. However, changes in pre- and post-diagnostic
PA levels and their association with breast cancer survival
have so far received limited attention [11–13]. Further-
more, it is import to understand whether increasing PA
after cancer diagnosis is beneficial for breast cancer survi-
vors, and if increased post-diagnostic PA can in fact
improve survival.
In the present paper, we aimed to investigate pre- and
post-diagnostic PA levels, as well as changes in pre- and
post-diagnostic PA levels, and their association with all-
cause mortality and breast cancer-specific mortality in a
population-based sample of women with breast cancer
in Norway.
Methods
Study sample
We used data from a national cohort of 109,398 women
enrolled in the Norwegian Women and Cancer
(NOWAC) study between 1991 and 2003. The NOWAC
study is a prospective cohort study with a random sam-
ple of women aged 30–70 years drawn from the Na-
tional Population Register in Norway [14, 15]. Women
in the NOWAC study were linked to various
population-based registries using the unique, 11-digit,
national personal identification number.
Women in the NOWAC study completed an extensive
questionnaire, including questions on PA level, height
and weight, exogenous hormone use, previous illnesses,
smoking status and habits, alcohol consumption, educa-
tion, reproductive history, and dietary habits at enroll-
ment, and again at two separate follow-up periods.
Therefore, the present study had prospective data on PA
at enrollment and at follow-up.
Women diagnosed with a primary, invasive, malignant
neoplasm of the breast based on the 10th revision of the
International Statistical Classification of Diseases, Injur-
ies and Causes of Death (ICD-10) codes C50.0–50.9 [16]
were identified through record linkage to the Cancer
Registry of Norway, from which date of diagnosis and
tumor stage (by the pTNM system) were obtained.
Information on date of death or emigration was obtained
through record linkage to the Norwegian National
Population Register. Information on cause of death was
obtained through record linkage to the National Register
for Causes of Death, in which physician-assigned ICD-
10 codes for cause of death are given. We categorized
these causes into all-causes combined (i.e., all-cause
mortality) and breast cancer-specific mortality. Follow-
up time was defined as the interval between the date of
completion of the first follow-up questionnaire after
breast cancer diagnosis and date of death from breast
cancer, date of death from any other cause, date of emi-
gration, or 31 December 2012 (last complete follow-up
date), whichever came first.
We identified 3,867 women with a diagnosis of breast
cancer recorded in Cancer Registry of Norway during
the study period. We excluded 2,540 women due to
missing information on PA levels, 437 of whom died be-
fore the second follow-up. This left 1,327 women with
information on PA levels at enrollment and at follow-up
in the final study sample. To evaluate the representative-
ness of the study sample, we compared selected charac-
teristics at enrollment of excluded women and of our
study sample. The Regional Ethical Committee and the
Norwegian Data Inspectorate approved the NOWAC
study. All women gave written informed consent prior
to their participation in the NOWAC study.
Assessment of physical activity and covariates
PA was defined in the NOWAC study questionnaire as
follows: “By physical activity we mean activity both at
work and outside work, at home, as well as training/ex-
ercise and other physical activity, such as walking, etc.
Please mark the number that best describes your level of
physical activity; 1 being very low and 10 being very
high”. Thus PA level was assessed by self-report on an
ordinal scale of 1 to 10. This PA scale has been validated
[17], and refers to the total amount of PA across differ-
ent domains, including recreation, occupation, transpor-
tation, and household in one global score. Moderate, but
significant (P < 0.001) Spearman’s rank correlation coef-
ficients were found (range: 0.36–0.46) between PA level
at enrollment and concurrent outcomes from criterion
measures of a combined sensor monitoring heart rate
and movement. The scale ranged from 1 (very low) to
10 (very high), and corresponded to mean values of 0.8
and 3.4 h/day of moderate/vigorous PA, respectively,
with a linear increase (P for trend <0.001), and appeared
valid to rank PA level in Norwegian women, but not to
quantify a definite dose of PA [17].
Pre-diagnostic PA level in the present analysis refers to
PA level at enrollment. Post-diagnostic PA level refers to
the PA level reported in first follow-up questionnaire
completed after breast cancer diagnosis.
Information on covariates was also obtained from the
NOWAC study questionnaire. Information on height
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and weight was used to calculate body mass index (BMI,
weight (kg)/squared height (m)). Time from breast cancer
diagnosis to post-diagnostic PA assessment was calculated
as the number of days between diagnosis and the comple-
tion of the applicable follow-up questionnaire.
Statistical analyses
Descriptive statistics (means and standard deviations
(SD)) were conducted. Multivariable Cox proportional
hazard models were used to estimate hazard ratios (HR)
and 95 % confidence intervals (CI). Tests for homogen-
eity were conducted using Wald statistics. Analyses in-
cluded the association of pre- and post-diagnostic PA
level and changes in pre- and post-diagnostic PA levels
with the two outcomes of interest: all-cause mortality
and breast cancer-specific mortality.
When analyzing the association between pre-diagnostic
and post-diagnostic PA levels and all-cause and breast
cancer-specific mortality, the 10 levels of the PA scale
were collapsed into 5 as follows: 1–2, 3–4, 5–6, 7–8, and
9–10. In analyses of the change in pre- and post-
diagnostic PA levels, a PA level ≥5 was considered active;
we defined reduced PA level as a pre-diagnostic PA level
≥5 and post-diagnostic PA level <5; women with pre- and
post-diagnostic PA levels <5 were categorized as main-
tained inactive; increased PA level was defined as a pre-
diagnostic PA level <5 and a post-diagnostic PA level ≥5;
and women with pre- and post-diagnostic PA levels ≥5
were categorized as maintained active. The multivari-
able models were adjusted for age at diagnosis, tumor
stage (I, II, III, IV and unknown), pre-diagnostic PA
levels (in models with post-diagnostic PA as the
exposure) and number of days between breast cancer diag-
nosis and post-diagnostic PA assessment (≤365/>365 days).
Additional analyses were conducted separately by age at
diagnosis (34–49 and 50–74 years) and post-diagnostic
BMI (<25 and ≥25 kg/m2). Stratified analyses for
change in pre- and post-diagnostic PA levels were
also done in subgroups of change in pre-and post-
diagnostic BMI, defined as unchanged <25 kg/m2,
weight gain (from BMI <25 to ≥25 kg/m2), weight
loss (from ≥25 to <25 kg/m2) and unchanged ≥25 kg/
m2. However, as we did not have the study power ne-
cessary to demonstrate statistically significant differ-
ences due of the small number of events in some of
the subgroups, these results are not reported. We also car-
ried out analyses that excluded women with a post-
diagnostic PA assessment ≤365 days after breast cancer
diagnosis to avoid bias due to possible declining PA prior
to and after breast cancer diagnosis. Sensitivity analyses
were carried out including other covariates, such as hor-
monal therapy (menopausal) use (ever/never), and comor-
bidities, such as diabetes and cardiovascular diseases,
smoking status (ever/never), pack-years smoked, alcohol
consumption (g/day), and duration of education (years).
However, as these covariates had no statistically significant
impact on the investigated associations, these analyses are
not reported in the main results. Possible departures from
linearity in the association between pre- and post-
diagnostic PA levels and all-cause mortality were assessed
using cubic spline regression [18]. The proportional haz-
ard assumption was checked using Schoenfeld residuals
and Kaplan-Meier plots, which suggested no evidence of
deviation from proportionality. All the analyses were per-
formed using the statistical package STATA, version 13,
with all statistical tests two-sided and conducted at the
0.05 significance level.
Results
Mean follow-up time in the study sample was 10.6 years
(range 0.92–21.5). In total 197 women died during
follow-up. The causes of death were: breast cancer
(78.7 %), other cancers (13.2 %), and other causes
(8.1 %) (Table 1). At the end of follow-up, 1,130 women
were still alive, two of whom had emigrated and were
censored at the time of emigration. The women in the
study sample were younger than excluded women at
breast cancer diagnosis (53.3 versus 59.3 years), had a
slightly longer duration of education (1 year), fewer
women in the study sample were current smokers (4 %),
and alcohol consumption in the study sample was some-
what higher than that among excluded women (3.98 ver-
sus 3.28 g/day) (data not shown). There was only a
negligible difference in PA at enrollment between in-
cluded and excluded women (5.6 versus 5.5) (data not
shown). A higher proportion of women who were
excluded due to missing post-diagnostic PA assessment
had stage I breast tumors (data not shown). Most
women (90.6 %) in the study sample were postmeno-
pausal at breast cancer diagnosis and mean age at death
was 60 years. There was no statistically significant differ-
ence in age at diagnosis among women with different PA
levels. Moreover, there were no differences in pre-
diagnostic PA levels between women who were diagnosed
shortly after enrollment and those diagnosed several years
after enrollment, or in post-diagnostic PA levels by time
from diagnosis to follow-up questionnaire (data not
shown). Post-diagnostic PA level was not significantly
different among women with different tumor stages at
diagnosis (data not shown). The mean time between the
date of pre-diagnostic PA assessment and date of diagnosis
was 6.6 years (SD 3.87), while the mean time from the date
of diagnosis to the post-diagnostic PA assessment was
3.08 years (SD 2.07).
Nine hundred eighty women had a pre-diagnostic PA
level of active (PA level ≥5); 79.6 % maintained this PA
level post-diagnosis, whereas the rest had reduced PA
levels (Fig. 1). Half of the women who reported pre-
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diagnostic PA levels of inactive had increased PA levels.
The result was a distribution of post-diagnostic PA levels
that was nearly identical to that of the pre-diagnostic PA
levels, with 28 % of women classified as inactive and
72 % as active (Fig. 1). More than 80 % of the women
who changed their PA levels moved only 1–2 levels on
the PA scale. Pre- and post-diagnostic BMI was inversely
associated (P < 0.001) with post-diagnostic PA level (i.e.,
the lower the pre- or post-diagnostic BMI the higher the
post-diagnostic PA level) (data not shown). Overall,
there was a significant increase in mean post-diagnostic
BMI compared to pre-diagnostic BMI, indicating that
the women gained weight after breast cancer diagnosis,
as no differences in height were observed (Table 1). The
increase in BMI observed in our study sample was simi-
lar to that seen during follow-up in the full NOWAC
study cohort (data not shown).
Pre-diagnostic physical activity level
Pre-diagnostic PA level was not associated with all-cause
or breast cancer-specific mortality (Fig. 2). The HR esti-
mates did not change significantly when BMI, use of
hormone therapy, or smoking status were added to the
model, nor when stratified by BMI (<25 or ≥25 kg/m2)
(data not shown).
Post-diagnostic physical activity level
There was a statistically significant trend of decreas-
ing all-cause mortality with increasing post-diagnostic
PA levels (P < 0.001). Compared to women with a PA
level of 5–6, women with a PA level of 1–2 had an
almost three-fold increased all-cause mortality risk
(HR = 2.83, 95 % CI 1.71–4.68), while women with a
PA levels of 9–10 had a HR of 0.46 (95 % CI 0.17–
1.28) (Fig. 2). The findings were similar for breast
cancer-specific mortality (Fig. 2). These results were
consistent across sensitivity analyses adjusted for age,
tumor stage, pre-diagnostic PA level, and time from
breast cancer diagnosis to post-diagnostic PA assessment;
and also when use of hormone therapy, BMI, and smoking
were added to the multivariable models (data not shown).
Despite significant trends in the association between post-
diagnostic PA level and all-cause mortality, the spline
regression analysis indicated that the association was
stronger for PA levels <5, while the association for
PA levels ≥5 did not reveal a similar steep slope
(Fig. 3). Analyses stratified by BMI (<25 or ≥ 25 kg/
m2) indicated similar, statistically significant trends of
reduced all-cause and breast cancer-specific mortality
with increasing post-diagnostic PA levels for women
with a BMI <25 kg/m2 (Additional file 1). This was
true also for women with BMI ≥25 kg/m2 and low
levels of post-diagnostic PA (Additional file 1), whereas
women with a BMI ≥25 kg/m2 and the highest level of PA
seemed to have an increased risk, though it was not
significant. Reduced all-cause mortality related to
post-diagnostic PA level was observed in women
younger than 50 years of age (P for trend = 0.030)
and those aged 50 years or older (P for trend <0.001);
however, among women with a PA level of 1, the
mortality risk was significantly stronger among
women aged 50 years or older compared to those
younger than 50 years of age (Additional file 2). The
results were consistent for breast cancer-specific mor-
tality (Additional file 2).
Table 1 Selected characteristic of 1,327 women diagnosed with
breast cancer in the Norwegian Women and Cancer study with
complete information on pre- and post-diagnostic physical
activity (PA) levels, 1991-2011
Characteristic
Age at enrollment, mean (SD) 46.7 (7.0)
Age at breast cancer diagnosis, mean (SD) 53.3 (6.7)
Duration of mean follow-up, years (range) 10.6 (0.92–21.5)
Tumor stage, n (%)
I 591 (44.5)
II 534 (40.2)
III 25 (1.8)
IV 20 (1.5)
Unknown 158 (11.9)
Cause of death, n (%)
Breast cancer 155 (78.7)
Other cancers 26 (13.2)
Other causes 16 (8.1)
Postmenopausal at diagnosis (%) 1,202 (90.6)
Pre-diagnostic PA, mean (SD) 5.6 (1.85)
Post-diagnostic PA, mean (SD) 5.5 (1.83)
BMI (kg/m2) at enrollment, mean (SD) 23.6 (3.7)
BMI (kg/m2) after breast cancer diagnosis, mean (SD) 25.2 (4.0)
Hormone therapy use at enrollment (ever), n (%) 338 (23.8)
Comorbidities at enrollment, n (%)
Diabetes 16 (1.1)
Cardiovascular diseases 58 (4.1)
Smoking status at enrollment, n (%)
Current 421 (31.9)
Former 436 (33.1)
Pack-years smoked at enrollment (ever), mean (SD) 8.7 (7.7)
Alcohol consumption (g/day) at enrollment, mean (SD) 3.98 (5.0)
Education (years) at enrollment, mean (SD) 12.7 (3.5)
SD standard deviation, BMI body mass index
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Changes in pre- and post-diagnostic physical activity
levels
Compared to women who maintained a PA level of
active, all-cause mortality (HR = 1.76, 95 % CI 1.21–2.56)
and breast cancer-specific mortality (HR = 2.05, 95 % CI
1.35–3.10) were both statistically significantly increased
among women with reduced PA levels. This was also
true for women who maintained a PA level of inactive
compared to those who maintained a PA level of ac-
tive, though this result was not significant (Table 2).
Women with increased PA levels had a higher risk of
all-cause and breast cancer-specific mortality, but this
risk was not statistically significant (Table 2). The re-
sults were consistent across models adjusted for BMI
(data not shown).
Discussion
In this prospective study of women with breast cancer,
pre-diagnostic PA levels had no impact on all-cause and
breast cancer-specific mortality, regardless of body size
or age at diagnosis. Conversely, post-diagnostic PA levels
decreased all-cause and breast cancer-specific mortality
significantly in a dose–response manner, and these find-
ings were consistent across different BMI groups. How-
ever, all-cause mortality was considerably increased
among women with a PA level of 1–2 (on a scale of 10)
who were older than 50 years as compared to younger
women with the same PA level. Women with breast can-
cer who had reduced PA levels or maintained an inactive
PA level had a substantial increase in all-cause mortality
and breast cancer-specific mortality as compared to
those who maintained an active PA level (i.e. ≥5).
Pre-diagnostic physical activity level and all-cause and
breast cancer-specific mortality
Findings from a recent review by Schmid and Leitzmann
[6] indicated a decreased risk of all-cause (HR = 0.77, 95 %
CI 0.66–0.90) and breast cancer-specific (HR = 0.77, 95 %
CI 0.69–0.88) mortality associated with pre-diagnostic PA
level, whereas our findings showed no such association.
However, only two of the studies [12, 19] included in the
meta-analysis assessed total PA and all-cause and breast
cancer-specific mortality; the remainder of the studies
reported only recreational PA [6]. In the recent, up-
dated meta-analysis from the Continuous Update Pro-
ject of the World Cancer Research Fund [20], which
includes the same two studies [12, 19], total pre-
diagnostic PA level showed an inverse, non-significant
association with all-cause mortality (HR = 0.83, 95 %
CI 0.62–1.12), with similar findings for breast cancer-
specific mortality (HR = 0.80, 95 % CI 0.59–1.10). For
recreational PA, the meta-analysis of the Continuous
Update Project included eight studies on all-cause
mortality and seven studies on breast cancer-specific
mortality; their findings indicated a significant reduc-
tion in all-cause and breast cancer-specific mortality
(26 % and 24 %, respectively) [20]. However, there
was heterogeneity between the included studies, espe-
cially related to the methods used to measure PA,
which precluded analyses of dose–response in the
meta-analysis.
Our results did not change when analyses were
stratified by BMI. Other studies have found significant
associations between recreational pre-diagnostic PA
level and all-cause mortality in women with a pre-
diagnostic BMI <25 kg/m2, but not for women with a
Fig. 1 Changes in pre- and post-diagnostic physical activity (PA) levels of 1,327 women diagnosed with breast cancer in the Norwegian Women
and Cancer study. Inactive = PA level 1–4, Active = PA level 5–10. Reduced PA level = pre-diagnostic PA level ≥5 and post-diagnostic PA level <5,
Maintained inactive = pre- and post-diagnostic PA levels <5, Increased PA level = pre-diagnostic PA level <5 and a post-diagnostic PA level ≥5,
Maintained active = pre- and post-diagnostic PA level ≥5
Borch et al. BMC Cancer  (2015) 15:967 Page 5 of 10
pre-diagnostic BMI ≥25 kg/m2 [21], while the opposite
was found in a study by Abrahamson and colleagues [22].
Cleveland and colleagues [23] reported that recreational
pre-diagnostic PA level was inversely related to all-cause
mortality, independent of BMI.
Post-diagnostic physical activity level and all-cause and
breast cancer-specific mortality
Our analysis showed a significant trend of decreased all-
cause and breast cancer-specific mortality associated
with post-diagnostic PA levels ≥5. Of three published
studies investigating total post-diagnostic PA, only the
Health, Eating, Activity and Lifestyle (HEAL) study [12]
reported a significant reduction in all-cause mortality
related to total post-diagnostic PA level; the other two
studies found an inverse relationship, but it was not sta-
tistically significant [13, 24]. The findings of the latest
meta-analysis, which included these three studies, con-
firmed an inverse relationship for all-cause mortality
(HR = 0.63, 95 % CI 0.41–0.97), but this relationship was
Pre−diagnostic
PA level
1
2
3
4
5
N deaths
5
48
86
42
16
All−cause mortality
HR (95% CI)
0.65 (0.24, 1.61)
1.04 (0.73, 1.49)
1.00 (ref)
0.77 (0.53, 1.12)
1.39 (0.80, 2.40)
0.10 0.25 0.50 1.0 2.0 4.0
N deaths
4
39
70
31
11
Breast cancer−specific mortality
HR (95% CI)
0.66 (0.24, 1.81)
1.01 (0.68, 1.51)
1.00 (ref)
0.68 (0.44, 1.05)
1.06 (0.55, 2.04)
0.10 0.25 0.50 1.0 2.0 4.0
Post−diagnostic
PA level
1
2
3
4
5
N deaths
20
51
82
40
4
All−cause mortality
HR (95% CI)
2.83 (1.71, 4.68)
1.25 (0.88, 1.80)
1.00 (ref)
0.74 (0.50, 1.09)
0.46 (0.17, 0.1.28)
0.10 0.25 0.50 1.0 2.0 4.0
N deaths
18
41
62
31
3
Breast cancer−specific mortality
HR (95% CI)
3.28 (1.91, 5.64)
1.34 (0.89, 2.01)
1.00 (ref)
0.75 (0.47, 1.17)
0.50 (0.15, 1.62)
0.10 0.25 0.50 1.0 2.0 4.0
Fig. 2 Hazard ratios (HR) and 95 % confidence intervals (CIs) of all-cause and breast cancer-specific mortality according to pre-diagnostic and
post-diagnostic physical activity (PA) levels among 1,327 women from the Norwegian Women and Cancer study, 1991–2011. Multivariable model
for pre-diagnostic PA adjusted for age and tumor stage and for post-diagnostic PA level adjusted for age, tumor stage, pre-diagnostic PA level
and time from diagnosis to post-diagnostic PA assessment ≤365/>365 days
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not statistically significant for breast cancer-specific
mortality (HR = 0.80, 95 % CI 0.59–1.10) and no dose–
response relationship was observed [20]. Furthermore,
the same meta-analysis for recreational post-diagnostic
PA reported a reduced breast cancer mortality of 24 %
[20]. Although the relationship between recreational
post-diagnostic PA level and all-cause mortality appears
to be stronger, studies on this topic are heterogeneous
[20]; therefore extra caution must be taken when inter-
preting their results. In the Women’s Health Initiative
Cohort (WHI), Irwin and colleagues [11] observed a
46 % reduction in all-cause mortality and a 39 % reduc-
tion in breast cancer-specific mortality when comparing
women with the lowest versus the highest recreational
PA levels. The Long Island Breast Cancer study [25] in-
vestigated recreational post-diagnostic PA and survival
after breast cancer diagnosis and found that, compared
to inactive women, women who were highly active (>9.0
MET h/week) after diagnosis reduced their all-cause
mortality (HR = 0.3, 95 % CI 0.22–0.48) and their breast
cancer-specific mortality (HR = 0.27, 95 % CI 0.15–0.46).
In our study there was no significant difference in the
relationship between post-diagnostic PA levels and all-
cause mortality and breast cancer-specific mortality for
women with BMI <25 kg/m2, however for women with a
BMI ≥25 kg/m2 and the highest post-diagnostic PA
levels, all-cause and breast cancer-specific mortality in-
creased. These results should be interpreted with cau-
tion, as there were a small number of events in some of
the subgroups, and the test for homogeneity was not
significant. Other studies reported no difference in the
impact of post-diagnostic PA level by BMI, menopausal
status, time since diagnosis, or tumor hormone receptor
status [6, 25].
We found that, compared to women below 50 years of
age, women aged 50 years or over at breast cancer diagno-
sis had a higher risk of all-cause and breast cancer-specific
mortality if they reported very low post-diagnostic PA
Fig. 3 Log relative hazard with 95 % confidence intervals of all-cause mortality by post-diagnostic physical activity (PA) level using cubic regression splines
Table 2 Hazard bratios (HR) and 95 % confidence intervals (CIs) by all-cause mortalitya and breast cancer-specific mortalityb and
change in pre- to post-diagnostic PA level among 1,327 women from the Norwegian Women and Cancer study, 1991–2011
Changes in PA level N deaths All-cause mortality HR (95 % CI)c N deaths Breast cancer-specific mortality HR (95 % CI)c
Maintained inactive 29 1.74 (1.00, 3.05) 23 1.66 (0.88, 3.12)
Reduced PA 42 1.76 (1.21, 2.56) 36 2.05 (1.35, 3.10)
Maintained active 102 1.00 (ref) 76 1.00 (ref)
Increased PA 24 1.23 (0.69, 2.18) 20 1.20 (0.63, 2.28)
aAll causes of death combined
bBreast cancer as underlying cause of death
cMultivariable model adjusted for age, tumor stage at diagnosis and time from diagnosis to PA assessment ≤365/>365 days
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levels. Thus, PA seems to be of particular importance
among older women, since their overall mortality risk is
already higher due to age and risk of other comorbidities.
Older breast cancer patients are a vulnerable group due to
decreased physical functioning, and PA could play an im-
portant role in sustaining functional mobility [26]. Most
importantly, our study revealed a potential decreased all-
cause and breast cancer-specific mortality among women
with breast cancer that had post-diagnostic PA levels of at
least 5. PA is a modifiable behavior, which can to a large
extent be controlled by women with breast cancer.
Changes in pre- and post-diagnostic physical activity
levels and all-cause and breast cancer-specific mortality
To our knowledge, there are few studies on the relation-
ship between changes in pre- and post-diagnostic PA
levels and all-cause and breast cancer-specific mortality
[11–13]. The WHI study reported a significant, reduced
all-cause mortality of 33 % when recreational PA in-
creased from before to after breast cancer diagnosis, but
no associations were found when PA decreased after
diagnosis.[11]. The HEAL study reported significant, in-
creased all-cause mortality with decreasing PA [12].
However, neither study could confirm a significant re-
duction in breast cancer-specific mortality [11, 12]. The
Women’s Healthy Eating and Living study found no
association between change in PA level post-diagnosis
and all-cause mortality [13]. Our findings for all-cause
mortality and breast cancer-specific mortality revealed
that maintaining an inactive PA level or reducing one’s
PA level after breast cancer diagnosis can lead to a
higher mortality risk, even if we failed to demonstrate
that increasing PA levels yielded a lower risk. Also, it
seems that a change of one or two levels on the PA scale
is sufficient to drive the associations, indicating that
small changes are of importance. A substantial propor-
tion of women in our study who were active before
breast cancer diagnosis reported lower PA levels after
diagnosis. It was beyond the scope of our study to inves-
tigate the reasons for this decrease, but it reveals a
potential for interventions aiming to decrease all-cause
and breast cancer-specific mortality.
Strengths and limitations
Study strengths include a population-based cohort, with
complete assessment of breast cancer incidence and
death, taking advantage of the population-based cancer
and death registries in Norway. Moreover, PA was
assessed prospectively before diagnosis. The PA scale
used in this study has been validated through moderate
correlations that are considered sufficient to differentiate
between different PA levels in a population of Norwe-
gian women [17]. However, the PA assessment may not
apply to women in other countries. The PA assessment
in this study comprised all areas of PA, not only recre-
ational PA. However, we are aware that a total self-
reported measure cannot differentiate intensity, duration,
and frequency of PA, nor the type of PA. A recently pub-
lished study by de Glas and colleagues suggested that the
intensity of PA is not related to the association between
PA and improved overall survival in women with breast
cancer [26].
Study limitations include the absence of information
on breast cancer treatment. However, we did adjust for
tumor stage at diagnosis. In Norway, cancer treatment
follows national guidelines by tumor stage, thus, stage
can be considered a valid surrogate variable for breast
cancer treatment, with rare exceptions. Moreover, in the
HEAL study, which adjusted for tumor stage, further
adjustment for treatment did not change the HR [12].
Furthermore, it was not possible to perform subgroup
analysis by tumor receptor status in our study due to the
small number of cases in each subgroup. As most of the
women were postmenopausal at cancer diagnosis, we
could not perform subgroup analysis by menopausal sta-
tus. We performed analyses including several variables
that could be considered potential confounders in the
association between PA and breast cancer risk, such as
BMI, use of hormone therapy, other comorbidities, edu-
cation, smoking, and alcohol consumption. However, as
the inclusion of these variables did not change the HR
estimates, we omitted these in the final analysis. More-
over, the potential for residual confounding remains.
Measurement errors in self-reported information cannot
be ruled out; however such an error would likely lead to
a non-differential bias and the potential underestimation
of the true effect. If breast cancer patients had been less
physically active due to symptoms of the disease at the
time of PA assessment, the bias of reversed causality
could threaten the results. However, we did not discover
any differences in the estimates when including women
with a post-diagnostic PA assessment shortly after diag-
nosis compared to those assessed 1 year after diagnosis,
indicating that our findings are likely not due to reverse
causation. Moreover, the results did not reveal any dif-
ferences in the post-diagnostic PA levels across different
tumor stages. Women who died before the second
follow-up period did not complete both questionnaires.
Excluded women who did not completing the second
follow-up questionnaire were older at time of breast
cancer diagnosis, had a slightly lower alcohol consump-
tion, were more likely to be current smokers, and had a
higher proportion of stage I tumors. However, these are
not very large differences and we suspect this did not
affected the results in a notable manner.
Individual disease management is of great importance
to improve long-term outcomes after breast cancer diag-
nosis. Current international recommendations for PA
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among breast cancer survivors are equal those for the gen-
eral population [27–30]. This implies exercising at least
150 min per week, including strength training at least
2 days per week [28, 30]. Although the evidence is incom-
plete, recommendations can be made to guide cancer sur-
vivors in their choices about PA and other modifiable
behaviors that may improve long-term outcomes.
Conclusion
Overall, we observed a dose–response trend in our data
for the association between post-diagnostic PA level and
both all-cause and breast cancer-specific mortality. We
also observed reduced mortality among women with a
post-diagnostic PA level ≥5. Our study adds to the
knowledge that a modifiable behavior such as PA after
breast cancer diagnosis may improve survival. Our re-
sults are very promising for women with breast cancer,
and indicate that health care professionals should con-
sider adding PA as a part of primary cancer treatment.
However, randomized controlled trials are needed to
further document this association.
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